Treatment withdrawal following remission in juvenile idiopathic arthritis: a systematic review of the literature

O Halyabar, J Mehta, S Ringold, DG Rumsey… - Pediatric Drugs, 2019 - Springer
Background Early diagnosis and treatment of juvenile idiopathic arthritis (JIA) with
conventional and biologic disease-modifying anti-rheumatic drugs have vastly improved …

Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors

J Gieling, B van den Bemt, E Hoppenreijs… - Pediatric …, 2022 - Springer
Background Biologic disease-modifying antirheumatic drugs (bDMARDs) have changed the
treatment of juvenile idiopathic arthritis (JIA) patients notably, as bDMARDs enable …

Novel DEK-targeting aptamer delivered by a hydrogel microneedle attenuates collagen-induced arthritis

J Cao, J Su, M An, Y Yang, Y Zhang, J Zuo… - Molecular …, 2020 - ACS Publications
DEK protein is critical to the formation of neutrophil extracellular traps (NETs) in rheumatoid
arthritis (RA). Blocking DEK using the aptamer DTA via articular injection has been shown to …

Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform

A Mak, NY Kow, NH Ismail, ND Anuar, NH Rutt… - Lupus, 2020 - journals.sagepub.com
Objective Conventional immunoassays detect autoantibodies related to systemic lupus
erythematosus (SLE) via recognition of epitopes on autoantigens expressed in their …

When to stop medication in juvenile idiopathic arthritis

D Abel, PF Weiss - Current Opinion in Rheumatology, 2023 - journals.lww.com
JIA is a heterogenous disease for which prospective clinical trials are needed to address the
question of when, how, and in whom to withdraw medication. Research investigating the …

Biomarkers of response to biologic therapy in juvenile idiopathic arthritis

V Choida, M Hall-Craggs, BR Jebson… - Frontiers in …, 2021 - frontiersin.org
Background: Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory
arthritis of childhood, characterized by various clinical phenotypes associated with variable …

Relationship between Jo‐1 B Cell Epitope Profile and Clinical Features of Anti‐Synthetase Syndrome

K Yamaguchi, Q Tang, JJ LaConti… - ACR Open …, 2024 - Wiley Online Library
Objective Anti–histidyl‐transfer RNA synthetase (Jo‐1) antibodies are associated with
myositis as well as different extramuscular organ complications comprising the anti …

[HTML][HTML] Poly (ADP-Ribosyl) Code Functions

NV Maluchenko, DO Koshkina, AV Feofanov… - Acta …, 2021 - ncbi.nlm.nih.gov
Poly (ADP-ribosyl) ation plays a key role in cellular metabolism. Covalent poly (ADP-ribosyl)
ation affects the activity of the proteins engaged in DNA repair, chromatin structure …

All hands on DEK

DM Bodine - The Journal of Clinical Investigation, 2019 - Am Soc Clin Investig
In this issue of the JCI, Capitano et al. demonstrate that the secreted form of the DNA-
binding chromatin factor DEK regulates hematopoiesis. It is known that DEK can be secreted …

Poly (ADP-Ribosyl) Code Functions

НВ Малюченко, ДО Кошкина, АВ Феофанов… - Acta Naturae …, 2021 - elibrary.ru
Поли (АDP-рибозил) ирование играет важнейшую роль в клеточном метаболизме.
Ковалентное поли (АDP-рибозил) ирование влияет на работу белков, вовлеченных в …